IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 154 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $134,820 | -29.6% | 14,000 | -23.1% | 0.00% | -50.0% |
Q1 2023 | $191,464 | -8.6% | 18,200 | +7.7% | 0.00% | 0.0% |
Q4 2022 | $209,391 | -84.2% | 16,900 | -84.0% | 0.00% | -83.3% |
Q1 2022 | $1,326,000 | -23.8% | 105,400 | -29.4% | 0.01% | 0.0% |
Q4 2021 | $1,740,000 | -35.7% | 149,200 | -28.0% | 0.01% | -57.1% |
Q3 2021 | $2,707,000 | -7.3% | 207,300 | -8.6% | 0.03% | -3.4% |
Q2 2021 | $2,920,000 | +17.3% | 226,900 | +1.9% | 0.03% | +20.8% |
Q1 2021 | $2,490,000 | +66.3% | 222,700 | +69.5% | 0.02% | +50.0% |
Q4 2020 | $1,497,000 | +61.0% | 131,400 | +27.1% | 0.02% | +45.5% |
Q3 2020 | $930,000 | +161.2% | 103,400 | +199.7% | 0.01% | +175.0% |
Q2 2020 | $356,000 | 0.0% | 34,500 | -2.3% | 0.00% | -20.0% |
Q1 2020 | $356,000 | +38.5% | 35,300 | +82.9% | 0.01% | +66.7% |
Q4 2019 | $257,000 | -51.6% | 19,300 | -45.5% | 0.00% | -50.0% |
Q4 2017 | $531,000 | -38.5% | 35,400 | -22.5% | 0.01% | -45.5% |
Q2 2017 | $863,000 | – | 45,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $191,107,000 | 16.54% |
HealthInvest Partners AB | 730,000 | $8,512,000 | 11.99% |
13D Management LLC | 612,853 | $7,146,000 | 2.74% |
Brown Capital Management | 16,257,899 | $189,567,000 | 1.57% |
BRIDGER MANAGEMENT, LLC | 929,714 | $10,840,000 | 1.40% |
Camber Capital Management LP | 3,000,000 | $34,980,000 | 1.20% |
Intrinsic Value Partners, LLC | 55,057 | $642,000 | 0.68% |
PRICE MICHAEL F | 520,000 | $6,063,000 | 0.67% |
CLARK ESTATES INC/NY | 355,000 | $4,139,000 | 0.61% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 8,145,674 | $94,979,000 | 0.56% |